Document is current
Any future updates will be listed below
-
Authors
Cai, Xue
Geyer, Philipp E.
Perez-Riverol, Yasset
Omenn, Gilbert S.
Dong, Lianhua
Winkler, Robert https://orcid.org/0000-0001-6732-1958
Ahadi, Sara
Lössl, Philip
Yu, Xiaobo
Chang, Cheng https://orcid.org/0000-0002-0361-2438
Ralser, Markus https://orcid.org/0000-0001-9535-7413
Jimenez, Connie R.
Zhao, Yang
Chen, Yu-Ju
Poon, Terence C. W.
Bache, Nicolai
Shi, Leming https://orcid.org/0000-0002-2981-4150
Dai, Xinhua
Wang, Ziyue
Zhu, Yi https://orcid.org/0000-0003-0429-0802
Fang, Xiang
Schwenk, Jochen M. https://orcid.org/0000-0001-8141-8449
Van Eyk, Jennifer E. https://orcid.org/0000-0001-9050-148X
Völker, Uwe https://orcid.org/0000-0002-5689-3448
Guo, Tiannan https://orcid.org/0000-0003-3869-7651
- License Information
-
More Information
Article History
Received: 3 March 2025
Accepted: 29 July 2025
First Online: 23 September 2025
Competing interests
: T.G. and Y. Zhu are shareholders of Westlake Omics. P.E.G. is an employee of Ions Biotechnologies. P.L. is an employee of Absea Biotechnology. N.B. is employee of Evosep. M.R. is the founder and shareholder of Eliptica. S.A. was a full-time employee of Alkahest, a Grifols company. J.M.S. is a scientific advisor for ABC Labs. The other authors do not have conflicts of interest related to this work.
